Management of Mixed Bacterial-Fungal Skin Infections

Diagnosis and Treatment Approach

The Infectious Diseases Society of America (IDSA) recommends treating the bacterial component of mixed bacterial-fungal skin infections with appropriate oral or topical antibiotics, and separately addressing any confirmed fungal infection with topical azoles like clotrimazole or miconazole 1
Most skin infections are either bacterial or fungal, not both simultaneously, and present with distinct symptoms such as purulence, warmth, and erythema for bacterial infections, and scaling, defined borders, and slower progression for fungal infections 1, 2

The IDSA guidelines specify oral dicloxacillin, cefalexin, clindamycin, or amoxicillin-clavulanic acid for impetigo, and similar agents for other bacterial skin infections 1
For purulent infections likely due to Staphylococcus aureus, recommended agents include (dicl)oxacillin, cefazolin, clindamycin, cefalexin, doxycycline, or sulfamethoxazole-trimethoprim 1
Topical mupirocin is more effective than bacitracin for bacterial skin infections 1

Apply clotrimazole 1% cream or miconazole 2% cream to affected areas for confirmed fungal infections, achieving 80-90% efficacy rates when used as directed 2
Clotrimazole may achieve results in shorter duration (3-7 days for most dermatophyte infections) 2
Continue treatment for 7-14 days depending on infection site and severity 2

Reassess the patient in 48-72 hours—if no improvement, consider resistant organisms or alternative diagnosis 3
Do not treat asymptomatic fungal colonization, approximately 10-20% of women normally harbor Candida species without requiring treatment 2
For severe or complicated fungal infections, multi-day regimens (7-14 days) are preferred over single-dose treatments 2